Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Melanomas that result from mutations in the gene encoding BRAF often become resistant to BRAF inhibition (BRAFi), with multiple mechanisms contributing to resistance. While therapy-induced autophagy promotes resistance to a number of therapies, especially those that target PI3K/mTOR signaling, its role as an adaptive resistance mechanism to BRAFi is not well characterized. Using tumor biopsies from BRAF(V600E) melanoma patients treated either with BRAFi or with combined BRAF and MEK inhibition, we found that BRAFi-resistant tumors had increased levels of autophagy compared with baseline. Patients with higher levels of therapy-induced autophagy had drastically lower response rates to BRAFi and a shorter duration of progression-free survival. In BRAF(V600E) melanoma cell lines, BRAFi or BRAF/MEK inhibition induced cytoprotective autophagy, and autophagy inhibition enhanced BRAFi-induced cell death. Shortly after BRAF inhibitor treatment in melanoma cell lines, mutant BRAF bound the ER stress gatekeeper GRP78, which rapidly expanded the ER. Disassociation of GRP78 from the PKR-like ER-kinase (PERK) promoted a PERK-dependent ER stress response that subsequently activated cytoprotective autophagy. Combined BRAF and autophagy inhibition promoted tumor regression in BRAFi-resistant xenografts. These data identify a molecular pathway for drug resistance connecting BRAFi, the ER stress response, and autophagy and provide a rationale for combination approaches targeting this resistance pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Inhibition of BRAFV600E with vemurafenib induces autophagy by inhibition of the mTOR signaling pathway, and autophagy has been shown to promote survival of melanoma cells after vemurafenib81,85.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [81]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Induction of autophagy has been suggested to be a pro-survival mechanism for melanoma cells79,81,82.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330 · cited 7×
“LC3 is an ubiquitin-like cytoplasmic protein that is conjugated to the surface of AVs as they are formed.”
InfluentialSelf-citationClonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J., & van Bree, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,188
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hauschild, A., Grob, J.-J., Demidov, L. V., Jouary, T., Gutzmer, R., Millward, M., Rutkowski, P., Blank, C. U., Miller, W. H., Kaempgen, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60868-x · Cited by 2,989
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response
Bertolotti, A., Zhang, Y., Hendershot, L. M., Harding, H. P., & Ron, D. (2000) · Nature Cell Biology · doi:10.1038/35014014 · Cited by 2,860
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Self-citationPhosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K.-J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L.-G., et al. (2006) · Nature Methods · doi:10.1038/nmeth947 · Cited by 2,419 · cited 9×
“PLA was performed using Duolink In Situ fluorescence technology (Olink Bioscience).”
Influential
Cited by
Items 401–490 of 490
Peng, Y., Wang, S.-R., Lai, Y.-F., Tsai, N., Lin, K., Lin, S., & Yang, T.-P. (2021) · Journal of Medicinal Food · doi:10.1089/jmf.2020.4777 · Cited by 2
Dekel‐Bird, N. P., Bialik, S., Itzhaki, O., Salame, T. M., Yaeli-Slonim, N., Levin‐Salomon, V., Dasari, S. K., Besser, M. J., & Kimchi, A. (2022) · Journal of Cancer Science and Clinical Therapeutics · doi:10.26502/jcsct.5079145 · Cited by 2
Endoplasmic Reticulum Stress and Emerging Therapeutic Targets in Cancer
Yeap, J. W., & Tan, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_271-1 · Cited by 2
Taskaeva, I. S., Shatruk, A., Ivanov, I., & Bgatova, N. P. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.102753 · Cited by 1
Pramanik, P., Das, T., Pal, U., & Rehman, I. (2025) · The Nucleus · doi:10.1007/s13237-025-00629-z · Cited by 1
4th international conference on tumor progression and therapeutic resistance: meeting report
Prabhu, V. V., & El‐Deiry, W. S. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1004928 · Cited by 1
Reinduktion zielgerichteter Therapie beim metastasierten Melanom
Reschke, R., Simon, J., & Ziemer, M. (2019) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13766_g · Cited by 1
The Unfolded Protein Response Role in Cancer
Martinotti, S., Bonsignore, G., & Ranzato, E. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_428 · Cited by 1
Recent advances in organelle-specific autophagy in melanoma
Qi, J., Zhang, Q., Wang, L. Y., Wen, X., He, G., & Jiang, X. L. (2024) · ONCOLOGIE · doi:10.1515/oncologie-2024-0228 · Cited by 1
Protein Kinase C Inhibition Overcomes Targeted Therapy Resistance in Cutaneous Melanoma
Stoffel, C. I., Eichhoff, O. M., Cheng, P. F., Seiler, L., Tellenbach, F. L., Dzung, A., Chiovaro, F., Dummer, R., & Levesque, M. P. (2025) · Experimental Dermatology · doi:10.1111/exd.70093 · Cited by 1
Massaro, R. R. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2014.tde-27052015-140543 · Cited by 1
Freire, J. J. D. (2000) · Historia Contemporánea · doi:10.1387/hc.15910 · Cited by 1
André, F. (2017) · theses.fr (ABES) · doi:10.70675/70763638z948az4836z9476zad606c3f72ed · Cited by 1
Grazia, G. (2016) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/grazia-giulia_phd2016-02-18 · Cited by 1
Impact of Targeting the Autophagy Related Gene Beclin 1 on the Immune Landscape of Melanoma
Arakelian, T. (2018) · theses.fr (ABES) · doi:10.70675/cd5f1ed6z9100z4dd3zb7fazb0537054f400 · Cited by 1
IDENTIFICATION OF NOVEL HEAT SHOCK RESPONSE MODULATORS FOR EXPERIMENTAL ANTI-MELANOMA INTERVENTION
Davis, A. L. (2015) · UA Campus Repository (The University of Arizona)
Oncogene-dependent regulation of autophagic flux in melanoma
White, K. A. (2015) · UNM’s Digital Repository (University of New Mexico)
Formulation and delivery of polymeric nanoparticle-assisted vaccine against melanoma
Niu, L. (2015) · University of Minnesota Digital Conservancy (University of Minnesota)
Autophagy as a Therapeutic Target in Cancer
Samson, J. M., & Thorburn, A. M. (2016) · Current cancer research · doi:10.1007/978-3-319-42740-9_1
Aptamer-mediated siRNA delivery to target colon cancer stem cells
Shamaileh, H. A. (2016) · Deakin Research Online (Deakin University)
Caddyshack therapeutics: overcoming glioblastoma adaptation
Gutmann, D. H. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox096
Metabolism in Pancreatic Cancer
Poursaitidis, I., & Lamb, R. F. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_68-1
Role of autophagy in normal and malignant hematopoiesis
Chen, X. (2017) · OhioLink ETD Center (Ohio Library and Information Network)
The role of autophagy inhibition in the enhanced cytotoxicity of temozolomide on melanoma cell lines
Ryabaya, O. O., Inshakov, A. N., Малышева, А. А., Abramov, I. S., Sholina, N. V., Khochenkov, D. A., & Степанова, Е. В. (2017) · Advances in molecular oncology · doi:10.17650/2313-805x-2017-4-3-75-82
Sharobim, M. (2016) · TSpace (University of Toronto)
Metabolism: The Sweet Spot in Melanoma Precision Medicine?
Baenke, F., Dhomen, N. S., Gottlieb, E., & Marais, R. (2017) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_28-1
Martínez, M. D. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Utilitat de la Immunohistoquímica i els Tissue Micro Arrays en l'estudi dels Tumors Sòlids
Maiques, Ó. (2017) · RECERCAT (Consorci de Serveis Universitaris de Catalunya)
Cellular response to stress: role of autophagy and cell death in caspase-9 deficient cells
Pakos‐Zebrucka, K. (2017) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/15883
Neyra, J. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2018.tde-30012018-101101
Kapoor, S., Spitz, D. R., Schultz, M. K., Simons‐Burnett, A. L., & Yang, L. (2018) · doi:10.17077/etd.n7p7-3p5r
Envolvimento da ativação de PAFR frente à quimioterapia no fenômeno de repopulação de melanomas
Jacomassi, M. D. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2019.tde-28022019-083226
The isolation, characterisation and role of cancer stem cells in oral cancer progression
Al-Magsoosi, M. J. N. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Molecularly Targeted Therapy for Patients with BRAF Wild-Type Melanoma
Chandra, S., McArthur, G. A., & Sosman, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-46029-1_55-1
Iyengar, K. (2019) · DigitalGeorgetown (Georgetown University Library)
Etude du rôle du facteur de transcription MITF et de ses cibles dans l'invasion des mélanomes
Nordlinger, A. (2019) · theses.fr (ABES) · doi:10.70675/1d810858zae33z4a82z8b52z1696e48fa0f0
The interplay of autophagy and epithelial-to-mesenchymal transition in cancer progression
Ryabaya, O. O., & Prokofieva, A. A. (2020) · Advances in molecular oncology · doi:10.17650/2313-805x-2020-7-2-8-19
Relevance of Autophagy in Cancer Stem Cell and Therapeutic
Sinha, N. (2020) · Springer eBooks · doi:10.1007/978-981-15-6930-2_10
Investigating the relationship between Ambra1, Autophagy and Cell proliferation in Melanoma
Ibrahim, M. (2021) · Sunderland Repository (University of Sunderland)
Molecularly Targeted Therapy for Patients with BRAF Wild-Type Melanoma
Chandra, S., McArthur, G. A., & Sosman, J. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-05070-2_55
Krause, D. S. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733947391.793583300
Martin, S., Dudek-Peric, A. M., Garg, A. D., Roose, H., Demirsoy, S., Van Eygen, S., Mertens, F., Vangheluwe, P., Vankelecom, H. E. J., & Agostinis, P. (2018) · Autophagy · doi:10.1080/15548627.2018.1467195
Inhibiting autophagy to fight BRAF resistance
(2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.50
Diehl, J. A. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727294526.793538085
Jiang, X., & Rothe, K. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733947391.793554355
Jiang, Z. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.6139
Mehnert, J. M., Mitchell, T. C., Huang, A. C. C., Alemán, T. S., Kim, B. J., Schuchter, L. M., Linette, G. P., Karakousis, G. C., Mitnick, S., Giles, L. R., et al. (2023) · doi:10.1158/1078-0432.22487199
Self-citationMehnert, J. M., Mitchell, T. C., Huang, A. C. C., Alemán, T. S., Kim, B. J., Schuchter, L. M., Linette, G. P., Karakousis, G. C., Mitnick, S., Giles, L. R., et al. (2023) · doi:10.1158/1078-0432.22487199.v1
Self-citationShen, J., Fan, Z., Ren, L., Cheng, Y., & Wu, C.-W. G. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4894782
The assessment of therapeutic autophagy inhibition in NF1 mutated tumor cellsPreprint
Zahedi, S., Baird-Daniel, E., Williams, K. B., Williams, R. L., Morin, A., Crespo, M., Bratbak, E., Jones, K., Vibhakar, R., Foreman, N. K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.12.623325
Taskaeva, I. S., Shatruk, A., & Bgatova, N. P. (2025) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-025-06414-x
Endoplasmic Reticulum Stress and Emerging Therapeutic Targets in Cancer
Yeap, J. W., & Tan, M. L. (2025) · Springer eBooks · doi:10.1007/978-3-032-00771-1_271
Attack cancer: Through autophagic modulations as suppressor or promoter
Gupta, P., Parveen, S., Kumar, S., Ahtsham, A., & Banerjee, M. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i11.112313
Melanocortin subtype 1 receptor (MC1R) targeted radionuclide therapy for melanoma
Li, M. (2018) · Iowa Research Online (The University of Iowa) · doi:10.25820/etd.007196
Einfluss von Autophagie-modulierenden Wirkstoffen auf die Proliferation von oralen Tumorzelllinien
Sampers, R. (2023) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-32066
Yang, Y., Wang, S., Wang, X.-X., Guo, S., Wang, H., Shi, Q., Tian, Y., Wang, H., Zhao, T., Zhang, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26674694
Yang, Y., Wang, S., Wang, X.-X., Guo, S., Wang, H., Shi, Q., Tian, Y., Wang, H., Zhao, T., Zhang, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26674697
Yang, Y., Wang, S., Wang, X.-X., Guo, S., Wang, H., Shi, Q., Tian, Y., Wang, H., Zhao, T., Zhang, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25116175
Yang, Y., Wang, S., Wang, X.-X., Guo, S., Wang, H., Shi, Q., Tian, Y., Wang, H., Zhao, T., Zhang, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25116029
Retinal alterations associated with targeted cancer therapy
Fasolino, G. (2023) · VUBIR (Vrije Universiteit Brussel)
Benito-Jardón, L. (2020) · Docta Complutense (Universidad Complutense de Madrid)
DI GIORGIO, D. (2020) · Electronic Theses and Dissertations Repository (University of Pisa)
Barceló Gómez, C. (2019) · RECERCAT (Consorci de Serveis Universitaris de Catalunya)
The Role of Hippo Pathway as a Non-genetic Mechanism of Acquired Resistance to Targeted Therapies
Kouru, I. (2023) · UTUPub (University of Turku)
Targeting store-operated Ca2+ entry as a novel strategy to overcome treatment resistance in melanoma
Gutiérrez, D. M. V., Niemeyer, B. A., Kreis, S., & Bréchard, S. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189548
Zhi, D., Wu, B., Yang, J., Wang, D., Qiao, J., & Guo, F. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08547-x
Toma, B., Tanasa, M. P., & Danciu, M. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189580
Shimizu, T. (2016) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00073752
CD63発現の増加はBRAF変異メラノーマ細胞のBRAF阻害剤耐性を抑制する
工藤, 光. (2018) · Institutional Repositories DataBase (IRDB)
Stress du réticulum endoplasmique et tumorigenèse
Lebeau, J. (2014) · theses.fr (ABES) · doi:10.70675/839b6a32z2b3dz4071z94b3zd0866c8e0d06
Implication du facteur de transcription E2F1 dans le mélanome
Rouaud, F. (2015) · theses.fr (ABES) · doi:10.70675/1a597f86zbdbaz4becz834dz2d86e55bfe60
Rôle de la protéine RICTOR dans le développement des mélanomes
Jebali, A. (2020) · theses.fr (ABES) · doi:10.70675/468ac338zaceaz4caaza391zda7d8da0cb2a
Rôle de c-Jun dans la réponse aux inhibiteurs de la voie des MAPK dans les mélanomes
Pohorecka, M. (2018) · theses.fr (ABES) · doi:10.70675/4cf7db7bz9142z4de8zbcbbzd5860991d571
León, C. M. L. (2021) · theses.fr (ABES) · doi:10.70675/b398d551z7ae6z49baza757zfbb9b4ea4be1
Exploring the Role of Wt1/Spon2 Axis in Prostate Cancer Progression and Fibroblast Dynamics
Xue, D., Tan, L., Yang, F., Tian, X., Wu, X., & Zuo, Q. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70800
活性型がん遺伝子BRAFによるストレス適応応答制御機構の解明と治療への応用
永澤生久子, & Nagasawa, I. (2017) · Institutional Repositories DataBase (IRDB)
Morita, A., Rai, K., Kuribayashi, T., Tomida, S., Nishi, T., Hara, N., Makimoto, G., Ninomiya, K., Kubo, T., Ohashi, K., et al. (2026) · Lung Cancer · doi:10.1016/j.lungcan.2026.109516
Advances in Research on the Dual Roles of Endoplasmic Reticulum Stress Response in Tumors
李, 钰. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1672656
Cristea, A. M., Macasoi, I. G., ALI, D. H., Jupâneanț, R. A., Coricovac, D. E., Dehelean, C. A., Antal, D., Dumitraşcu, V., Jîjie, A.-R., Lăcătuș, M., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177676
Insights from Dictyostelium: Examining the role of cellular stress in Batten disease
Thanabalasingam, A. (2024) · Digital Collections (Trent University)
He, J.-L., Li, X., Xi, Z.-S., Wang, J., Wang, S., Wang, M.-Y., Chen, Z.-Y., Quan, L., Yue, B., & Zheng, B. (2026) · Research Square · doi:10.21203/rs.3.rs-10964447/v1
BindingDB (2021) · UC San Diego · doi:10.7270/q2rr22gw
Metadata
- Authors
- Ma, X.-H., Piao, S.-F., Dey, S., Mcafee, Q., Karakousis, G., Villanueva, J., Hart, L. S., Levi, S., Hu, J., Zhang, G., Lazova, R., Klump, V., Pawelek, J. M., Xu, X., Xu, W., Schuchter, L. M., Davies, M. A., Herlyn, M., Winkler, J., Koumenis, C., & Amaravadi, R. K.
- Affiliations
- University of Pennsylvania (US)
- The Wistar Institute (US)
- Yale University (US)
- Abramson Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-02-24
- Volume
- 124
- Issue
- 3
- Pages
- 1406-1417
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3934165
- OpenAlex
- W2119735934
- Cited by
- 457
- References
- 52
- Citations by year
- 2026: 11 · 2025: 36 · 2024: 39 · 2023: 27 · 2022: 37 · 2021: 40 · 2020: 40 · 2019: 35 · 2018: 44 · 2017: 44 · 2016: 48 · 2015: 31 · 2014: 24
- FWCI
- 20.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania
- National Institutes of Health
- National Cancer Institute (P01CA114046, R01CA139362, K01CA175269, K23CA120862, R01CA169134, R01CA094214, P30CA016672, P30CA010815, P30CA016520)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- melanoma, BRAF inhibitor resistance, BRAF V600E mutation, endoplasmic reticulum stress, autophagy, cytoprotective autophagy, GRP78, PERK, MEK inhibition, autophagy inhibition, combination therapy, PI3K/mTOR signaling, progression-free survival
- MeSH terms
- Vemurafenib, Endoplasmic Reticulum Chaperone BiP, Animals, Antineoplastic Agents, Autophagy, Humans, Indoles, Melanoma, Mice, Nude, Sulfonamides, Drug Resistance, Neoplasm, Mutation, Missense, MAP Kinase Signaling System, Xenograft Model Antitumor Assays, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, Cell Proliferation, Mice, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.